OBJECTIVE: To analyse the association between oral contraceptive use and the risk of uterine fibroids. DESIGN: We considered data collected in a case-control study on risk factors for uterine fibroids. PARTICIPANTS: We studied 843 women with uterine fibroids, whose clinical diagnosis dated back no more than two years. Controls were 1557 non-hysterectomised patients younger than 55 years admitted for acute, non-gynecological, non-hormonal, non-neoplastic conditions. RESULTS: A total of 254 cases (30.1%) and 360 controls (23.1%) reported ever using oral contraceptives: the odds ratio (OR) for ever vs never users was 1.1 (95% CI 0.8-1.3). The risk in current users was below unity when compared with never users (OR 0.3, 95% CI 0.2-0.6), while ex-users had a risk of fibroids comparable with never users (OR 1.1, 95% CI 0.9-1.4). The risk of uterine fibroids decreased with duration of oral contraceptive use: compared with never users, the estimated OR was 0.8 (95% CI 0.5-1.2) in ever users for four to six years and 0.5 (95% CI 0.3-0.9) for seven years or more (chi2 trend = 4.6, P = 0.03). CONCLUSIONS: Although the role of selection bias should be carefully evaluated, the present data suggest that uterine fibroids should not be considered a contra-indication for oral contraceptive use.
OBJECTIVE: To analyse the association between oral contraceptive use and the risk of uterine fibroids. DESIGN: We considered data collected in a case-control study on risk factors for uterine fibroids. PARTICIPANTS: We studied 843 women with uterine fibroids, whose clinical diagnosis dated back no more than two years. Controls were 1557 non-hysterectomised patients younger than 55 years admitted for acute, non-gynecological, non-hormonal, non-neoplastic conditions. RESULTS: A total of 254 cases (30.1%) and 360 controls (23.1%) reported ever using oral contraceptives: the odds ratio (OR) for ever vs never users was 1.1 (95% CI 0.8-1.3). The risk in current users was below unity when compared with never users (OR 0.3, 95% CI 0.2-0.6), while ex-users had a risk of fibroids comparable with never users (OR 1.1, 95% CI 0.9-1.4). The risk of uterine fibroids decreased with duration of oral contraceptive use: compared with never users, the estimated OR was 0.8 (95% CI 0.5-1.2) in ever users for four to six years and 0.5 (95% CI 0.3-0.9) for seven years or more (chi2 trend = 4.6, P = 0.03). CONCLUSIONS: Although the role of selection bias should be carefully evaluated, the present data suggest that uterine fibroids should not be considered a contra-indication for oral contraceptive use.
Entities:
Keywords:
Adult--women; Age Factors; Biology; Clinical Research; Contraception; Contraceptive Methods--side effects; Demographic Factors; Developed Countries; Diseases; Europe; Family Planning; Fibroids; Genitalia; Genitalia, Female; Italy; Mediterranean Countries; Neoplasms; Neoplasms, Benign; Oral Contraceptives--side effects; Physiology; Population; Population Characteristics; Research Methodology; Research Report; Risk Factors; Southern Europe; Urogenital System; Uterine Effects; Uterus; Women
Authors: Quanling Feng; John R Crochet; Qunsheng Dai; Phyllis C Leppert; Thomas M Price Journal: J Clin Endocrinol Metab Date: 2014-01-13 Impact factor: 5.958
Authors: Vanessa L Jacoby; Alison Jacoby; Lee A Learman; Michael Schembri; Steven E Gregorich; Rebecca Jackson; Miriam Kuppermann Journal: Eur J Obstet Gynecol Reprod Biol Date: 2014-09-16 Impact factor: 2.435
Authors: D Andrew Crain; Sarah J Janssen; Thea M Edwards; Jerrold Heindel; Shuk-mei Ho; Patricia Hunt; Taisen Iguchi; Anders Juul; John A McLachlan; Jackie Schwartz; Niels Skakkebaek; Ana M Soto; Shanna Swan; Cheryl Walker; Teresa K Woodruff; Tracey J Woodruff; Linda C Giudice; Louis J Guillette Journal: Fertil Steril Date: 2008-10 Impact factor: 7.329
Authors: Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg Journal: Am J Epidemiol Date: 2004-01-15 Impact factor: 4.897
Authors: Claire Templeman; Sarah F Marshall; Christina A Clarke; Katherine DeLellis Henderson; Joan Largent; Susan Neuhausen; Peggy Reynolds; Giske Ursin; Leslie Bernstein Journal: Fertil Steril Date: 2008-11-18 Impact factor: 7.329